SALIX PHARMACEUTICALS
Salix Pharmaceuticals is a specialty pharmaceutical company committed to the prevention and treatment of gastrointestinal (GI) disorders. For more than 20 years, they have licensed, developed, and marketed innovative products to treat GI problems. It's their mission to give healthcare providers and patients the most effective solutions in gastroenterology.
SALIX PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1989-01-01
Address:
Raleigh, North Carolina, United States
Country:
United States
Website Url:
http://www.salix.com
Total Employee:
501+
Status:
Active
Contact:
(919)862-1000
Email Addresses:
[email protected]
Total Funding:
750 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Google Universal Analytics Font Awesome IPv6 ReCAPTCHA JsDelivr
Similar Organizations
ZS Pharma
ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.
Current Advisors List
Carolyn Logan Member of the Board of Directors @ Salix Pharmaceuticals Board_member 2000-06-01
Current Employees Featured
Carolyn Logan
Carolyn Logan CEO @ Salix Pharmaceuticals CEO 2000-06-01
Thomas Hadley
Thomas Hadley VP - Head of Marketing @ Salix Pharmaceuticals VP - Head of Marketing 2015-04-01
Robert Spurr
Robert Spurr President @ Salix Pharmaceuticals President 2020-06-01
Howard Franklin
Howard Franklin Chief Medical Officer @ Salix Pharmaceuticals Chief Medical Officer 2018-01-01
Adam Derbyshire
Adam Derbyshire Chief Financial Officer @ Salix Pharmaceuticals Chief Financial Officer
Nicola Kayel
Nicola Kayel Vice President & GI Marketing @ Salix Pharmaceuticals Vice President & GI Marketing 2016-05-01
Ellen McKim
Ellen McKim SVP, Marketing @ Salix Pharmaceuticals SVP, Marketing 2000-09-01
Scruggs Rick
Scruggs Rick EVP Business Development @ Salix Pharmaceuticals EVP Business Development
Robert Rolleri
Robert Rolleri Executive Director, Clinical Development @ Salix Pharmaceuticals Executive Director, Clinical Development
Founder
Lorin Johnson
Stock Details
Company's stock symbol is NASDAQ:SLXP
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2013-11-07 | Santarus | Santarus acquired by Salix Pharmaceuticals | 2.6 B USD |
2011-11-08 | Oceana Therapeutics | Oceana Therapeutics acquired by Salix Pharmaceuticals | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2016-11-01 | Atlantic Healthcare | Salix Pharmaceuticals investment in Series B - Atlantic Healthcare | 24 M USD |
2013-01-01 | Atlantic Healthcare | Salix Pharmaceuticals investment in Series A - Atlantic Healthcare | 23.1 M USD |
Official Site Inspections
http://www.salix.com Semrush global rank: 1.97 M Semrush visits lastest month: 10.9 K
- Host name: 217.114.94.2
- IP address: 217.114.94.2
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
Loading ...